Cleveland Clinic Abu Dhabi Expands Research Addressing Community Health

ABU DHABI, July 6, 2023 (WAM) – Cleveland Clinic Abu Dhabi, an M42 company, is expanding its research efforts to address the UAE’s community health issues. The hospital has more than 200 active research studies, 60 of which he will start in 2022. Research focuses on a variety of important themes such as gastrointestinal disease, neurological disease, and heart disease.

In line with the Abu Dhabi Ministry of Health’s efforts to improve healthcare across the UAE population, Cleveland Clinic Abu Dhabi is using its research to advance treatment options in the UAE and GCC regions. The hospital is currently conducting three studies on liver health, breast cancer and obesity. These studies focused on Emirates populations and used a genome-based approach.

Genome-based research enables comparison and validation of results and can accelerate the development of new treatments and personalized medical options for these medical conditions. Cleveland Clinic Abu Dhabi invites the public to ensure the success of these efforts by enrolling as participants in future clinical trials.

“Our mission at Cleveland Clinic Abu Dhabi is to provide world-class care to the UAE community and the wider region,” said Dr. Sousan Abdel Rajig, Chief Academic Officer of Cleveland Clinic Abu Dhabi. Our multidisciplinary team, in conjunction with our research department, collaborates with universities and other strategic partners to advance community health care through a wide range of teaching and research efforts to develop new We are investing in the next generation of clinical caregivers and medical leaders to develop therapeutics, advanced diagnostics and preventive healthcare options that will benefit the UAE public for years to come.”

The first of the three studies, conducted in collaboration with another M42 company, the Imperial College London Diabetes Centre, examined people in the United Arab Emirates for obesity, diabetes and fatty liver disease. This is the first targeted prospective metabolic study. His second study, in collaboration with Khalifa University, is a study on obesity and bariatric surgery, the first genetic study of metabolic disease.

Finally, a pilot study focusing on breast cancer health awareness among women in the Emirates aims to identify disease patterns among local populations and raise awareness of the need for regular mammography screening. .

All three studies aim to strengthen healthcare in the UAE and were made possible by the participation of large numbers of study participants. Cleveland Clinic Abu Dhabi’s research projects and studies adhere to strict guidelines set by the Abu Dhabi Ministry of Health. Participants in these research projects are treated according to the highest security standards and are subject to the strictest confidentiality protections.